PL3154515T3 - Udoskonalenia kompozycji donosowych i sposób ich stosowania - Google Patents

Udoskonalenia kompozycji donosowych i sposób ich stosowania

Info

Publication number
PL3154515T3
PL3154515T3 PL15731092T PL15731092T PL3154515T3 PL 3154515 T3 PL3154515 T3 PL 3154515T3 PL 15731092 T PL15731092 T PL 15731092T PL 15731092 T PL15731092 T PL 15731092T PL 3154515 T3 PL3154515 T3 PL 3154515T3
Authority
PL
Poland
Prior art keywords
application
nasal compositions
nasal
compositions
Prior art date
Application number
PL15731092T
Other languages
English (en)
Inventor
Todor A POPOV
Original Assignee
Nasaleze Patents Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nasaleze Patents Limited filed Critical Nasaleze Patents Limited
Publication of PL3154515T3 publication Critical patent/PL3154515T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL15731092T 2014-06-10 2015-06-08 Udoskonalenia kompozycji donosowych i sposób ich stosowania PL3154515T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1410250.3A GB201410250D0 (en) 2014-06-10 2014-06-10 Improvements to nasal compositions and method of use thereof
PCT/GB2015/051661 WO2015189579A1 (en) 2014-06-10 2015-06-08 Improvements to nasal compositions and method of use thereof
EP15731092.1A EP3154515B1 (en) 2014-06-10 2015-06-08 Improvements to nasal compositions and method of use thereof

Publications (1)

Publication Number Publication Date
PL3154515T3 true PL3154515T3 (pl) 2021-08-09

Family

ID=51266948

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15731092T PL3154515T3 (pl) 2014-06-10 2015-06-08 Udoskonalenia kompozycji donosowych i sposób ich stosowania

Country Status (9)

Country Link
US (3) US20170239220A1 (pl)
EP (1) EP3154515B1 (pl)
JP (1) JP6762931B2 (pl)
CN (1) CN106794137B (pl)
BR (1) BR112016029013A2 (pl)
ES (1) ES2869912T3 (pl)
GB (1) GB201410250D0 (pl)
PL (1) PL3154515T3 (pl)
WO (1) WO2015189579A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201410250D0 (en) 2014-06-10 2014-07-23 Nasaleze Patents Ltd Improvements to nasal compositions and method of use thereof
CA2923767A1 (en) 2016-03-14 2017-09-14 Timothy R. St. Germain Method of using n-hydroxy-1,4-napthalenedione as a novel herbicide
CN106361688B (zh) * 2016-08-26 2019-12-06 朱高 鼻腔洗液及其制备方法和应用
CN106890197B (zh) * 2017-04-11 2018-07-31 成都益植生物科技有限公司 一种定植益生菌制剂及其应用和药物
CN107582573A (zh) * 2017-08-23 2018-01-16 江苏微康生物科技有限公司 一种益生菌滴剂及其制备方法
CN109966324A (zh) * 2017-12-27 2019-07-05 北京盈科瑞药物安全有效性研究有限公司 一种银杏叶提取物雾化吸入用溶液制剂及其制备方法
TR201900055A2 (tr) * 2019-01-03 2019-03-21 Helvacizade Gida Ilac Kimya Sanayi Ve Ticaret Anonim Sirketi Burun spreyi̇ formülasyonu
GB202001906D0 (en) * 2020-02-12 2020-03-25 Nasaleze Patents Ltd Compositions And Applications Thereof
AU2021276335A1 (en) * 2020-05-18 2023-01-19 University Of Louisville Research Foundation, Inc. Compositions and methods for prevention of Coronavirus infection
GB2611803A (en) 2021-10-15 2023-04-19 Nasaleze Patents Ltd Compositions of high viscosity
CN117771183B (zh) * 2024-02-27 2024-05-03 深圳大佛药业股份有限公司 一种盐酸羟甲唑啉喷雾剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
CA2583794C (en) * 2004-10-11 2015-05-26 Nasaleze Ppm Limited Compositions for intranasal administration
GB2423711B (en) * 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion
CN101564396A (zh) * 2009-06-15 2009-10-28 阳国平 治疗变应性鼻炎的两腔型鼻喷雾剂
GB201410250D0 (en) 2014-06-10 2014-07-23 Nasaleze Patents Ltd Improvements to nasal compositions and method of use thereof

Also Published As

Publication number Publication date
BR112016029013A2 (pt) 2017-08-22
EP3154515B1 (en) 2021-04-28
US20170239220A1 (en) 2017-08-24
CN106794137A (zh) 2017-05-31
ES2869912T3 (es) 2021-10-26
JP2017527608A (ja) 2017-09-21
RU2016151683A3 (pl) 2019-01-24
US20200054609A1 (en) 2020-02-20
RU2016151683A (ru) 2018-07-10
CN106794137B (zh) 2021-10-15
WO2015189579A1 (en) 2015-12-17
GB201410250D0 (en) 2014-07-23
EP3154515A1 (en) 2017-04-19
US11583519B2 (en) 2023-02-21
JP6762931B2 (ja) 2020-09-30
WO2015189579A9 (en) 2017-02-23
US20250268866A1 (en) 2025-08-28

Similar Documents

Publication Publication Date Title
KR20180084891A (ko) 구조 조성물 및 방법
DK3145493T3 (da) Fremgangsmåder og sammensætninger vedrørende exosomer
PL3265448T3 (pl) Proleki riluzolu i ich zastosowanie
PT3355990T (pt) Compostos semifluorados e as suas composições
PL3212225T3 (pl) Sposoby i kompozycje zmodyfikowanych limfocytów t
DK3104718T3 (da) Tobaksholdig gelsammensætning
DK3089741T3 (da) Farmaceutiske sammensætninger omfattende azd9291
DK3215173T3 (da) Glycopeptidsammensætninger
DK3182962T3 (da) Compositions and uses of amidine derivatives
EP2970569A4 (en) PERSISTENT CARBENE AND COMPOSITIONS WITH IT
DK3194564T3 (da) Trichodermasammensætninger og anvendelsesfremgangsmåder
LT3149345T (lt) Būdas dviem objektams sujungti
PT3261437T (pt) Compostos e composições fungicidas
GB201410250D0 (en) Improvements to nasal compositions and method of use thereof
IL248223A0 (en) Vaccine compositions
PT3200772T (pt) Composições farmacêuticas compreendendo alpelisib
DK3331498T3 (da) Nasalsammensætning
LT3013855T (lt) Mutavusio viii faktoriaus kompozicijos ir metodai
PL3613423T3 (pl) Kompozycje hialuronanu o dużej sprężystości i ich zastosowanie
BR112016021875A2 (pt) composição tópica
DK3200827T3 (da) Sammensætninger
DK3068428T3 (da) Annexin-ii-variant-sammensætninger og fremgangsmåder
DK3233104T3 (da) Immunterapi-behandlinger og -sammensætninger
EP2996685A4 (en) FLUID PROCESSING COMPOSITIONS AND METHODS
KR20180084930A (ko) 접착제 조성물 및 구조체